Today: 12 April 2026
Subscribe

Hawkish Fed Can’t Stop Nasdaq’s Record Tech Rally – What It Means for Investors

Hawkish Fed Can’t Stop Nasdaq’s Record Tech Rally – What It Means for Investors

The Federal Reserve cut interest rates by a quarter-point but signaled no guarantee of further easing in December, prompting traders to temper expectations. Tech earnings sent the Nasdaq to a 4.7% October gain, its longest winning streak since 2018, while Amazon shares hit a record high. A U.S. government shutdown delayed key economic data, forcing reliance on private reports.
3 November 2025
····
Tesla’s Stunning 2025 Comeback: TSLA Stock Soars Amid AI Ambitions, $1 Trillion Musk Bet & EV Wars

Tesla’s Stunning 2025 Comeback: TSLA Stock Soars Amid AI Ambitions, $1 Trillion Musk Bet & EV Wars

Tesla shares climbed to $458 on Nov. 3, up 13% year-to-date and near their 2024 record. Q3 revenue hit $28.1 billion on 497,000 deliveries, but EPS missed estimates at $0.50 as margins fell to 15.4%. U.S. regulators expanded a probe into Model Y door handles, and Tesla secured a $2.1 billion battery deal with Samsung SDI. The board is urging shareholders to approve Elon Musk’s $1 trillion pay package.
3 November 2025
·····
Rigetti Stock’s Quantum Roller Coaster: 3,000% Surge, Government Backing & Big Risks

Rigetti Stock’s Quantum Roller Coaster: 3,000% Surge, Government Backing & Big Risks

Rigetti Computing shares surged over 3,000% in the past year, peaking near $50 before retreating to the high-$30s after volatility tied to government funding talks. The company booked its first commercial quantum computer sales in September, worth $5.7 million. Q2 revenue fell 42% to $1.8 million, but Rigetti holds $572 million in cash. Analyst price targets vary widely, with recent downgrades citing valuation concerns.
3 November 2025
··
SoFi Stock Soars to New Highs After Record Earnings – Why Some Say It’s Just the Beginning

SoFi Stock Soars to New Highs After Record Earnings – Why Some Say It’s Just the Beginning

SoFi Technologies shares hit record highs near $31 after Q3 2025 revenue surged 38% to $950 million and net income more than doubled to $139 million. The company raised full-year guidance, now projecting 36% revenue growth. SoFi added 905,000 new members in the quarter, reaching 12.6 million. Wall Street remains cautious, with most analysts rating the stock Hold despite recent gains.
3 November 2025
···
Bitfarms (BITF) Skyrockets on AI Pivot – Bitcoin Miner’s 400% Rally and Future Outlook

Bitfarms (BITF) Skyrockets on AI Pivot – Bitcoin Miner’s 400% Rally and Future Outlook

Bitfarms Ltd. closed a $588 million convertible notes offering on October 21 to fund AI data center expansion, with notes convertible at $6.86 per share. Shares surged 428% in three months, reaching $4.20 in early November, and market cap stands at $2.3 billion. The company reported $245 million in trailing revenue and a net loss of $86 million. Bitfarms is shifting focus to HPC/AI amid rising mining difficulty.
3 November 2025
····
Plug Power’s High-Stakes Hydrogen Comeback: Stock Surge, CEO Shakeup & Big Deals Fuel 2025 Hopes

Plug Power’s High-Stakes Hydrogen Comeback: Stock Surge, CEO Shakeup & Big Deals Fuel 2025 Hopes

Plug Power shares traded near $2.70 on Nov. 3, 2025, rebounding from sub-$1 lows but still over 90% below 2021 highs. Q2 revenue rose 21% to $174 million, with gross margin improving to -31%. CEO Andy Marsh will step down by March 2026, succeeded by Jose Luis Crespo. The company signed a 2 GW electrolyzer deal with Allied Biofuels and expanded U.S. hydrogen and SAF partnerships.
3 November 2025
·
5 Dividend ETFs That Could Pay You for Life – One Could Turn $500/Month Into $680,000

5 Dividend ETFs That Could Pay You for Life – One Could Turn $500/Month Into $680,000

The Schwab U.S. Dividend Equity ETF (SCHD) yields about 3.9% annually with a 0.06% fee, while JPMorgan’s JEPI offers an 8.6% yield at a 0.35% expense ratio. As of early November 2025, SCHD trades near $26.50, VYM at $139, and JEPI at $57. Some niche ETFs show yields above 10%, but high payouts like TSLY’s 98% have come with steep losses, including a -34% one-year return.
3 November 2025
····
Record 2026 Tax Refund Surge Looms as New Tax Cuts Fuel a $50 Billion “Stimulus”

Record 2026 Tax Refund Surge Looms as New Tax Cuts Fuel a $50 Billion “Stimulus”

Americans are expected to receive tax refunds averaging $3,743—about $557 more than last year—when filing 2025 returns, due to retroactive tax cuts and unchanged IRS withholding tables. The changes, signed into law by President Trump in July, will deliver an estimated $50 billion in extra refunds, with most benefits going to higher earners. Economists warn the surge could temporarily boost consumer spending and inflation.
3 November 2025
·
Delisted Xbox 360 Games Suddenly Reappear – Backward Compatibility on the Horizon?

Delisted Xbox 360 Games Suddenly Reappear – Backward Compatibility on the Horizon?

Several previously delisted Xbox 360 games appeared on the Microsoft Store with a "Coming soon" label, despite no official announcement from Microsoft. The listings follow the July 2024 shutdown of the Xbox 360 marketplace. The move has fueled speculation about renewed backward compatibility efforts and possible emulator development. Licensing hurdles remain a barrier to reselling older titles.
3 November 2025
·
AI Chip Frenzy Sends Lam Research Soaring 117% – More Upside Ahead?

AI Chip Frenzy Sends Lam Research Soaring 117% – More Upside Ahead?

Lam Research shares have surged 117% year-to-date in 2025, far outpacing Nvidia and Broadcom. The company posted Q3 revenue of $5.32 billion, up about 28% year-over-year, and adjusted EPS jumped 46% to $1.26. Lam raised guidance for the next quarter, citing soaring demand for AI chipmaking equipment. CEO Tim Archer said AI data center investment is directly expanding Lam’s market.
3 November 2025
···
ClearPoint Neuro (CLPT) Stock Skyrockets on Brain Therapy Breakthroughs – 2025 Deep Dive

ClearPoint Neuro (CLPT) Stock Skyrockets on Brain Therapy Breakthroughs – 2025 Deep Dive

ClearPoint Neuro shares surged to the mid-$20s in November 2025 after hitting a 52-week high near $30, driven by heavy trading and recent product breakthroughs. The company reported Q2 revenue of $9.2 million, up 17% year-on-year, but remains unprofitable. Its neuro devices gained expanded FDA clearance and international approvals. Analysts maintain buy ratings with price targets averaging $29.
3 November 2025
·
Hims & Hers Bets Big on “GLP-1 Microdosing” Weight-Loss Trend – Stock and Experts React

Hims & Hers Bets Big on “GLP-1 Microdosing” Weight-Loss Trend – Stock and Experts React

Hims & Hers said Oct. 29 it will offer clinician-supervised GLP-1 “microdose” plans using compounded semaglutide for metabolic health, priced at $1,200 for six months. The drugs, not FDA-approved, target patients with conditions like sleep apnea or high blood pressure. Medical experts warn safety data is limited and compounded versions carry risks. HIMS stock rose 2–3% after the announcement.
3 November 2025
···
CURE Pharmaceutical (CURR) Stock Skyrockets Amid Wellness Pivot – What’s Next for Investors?

CURE Pharmaceutical (CURR) Stock Skyrockets Amid Wellness Pivot – What’s Next for Investors?

CURE Pharmaceutical, now Avenir Wellness Solutions (AVRW), closed at $3.78 on Oct. 31, up 30.8% in one day and more than doubling over two weeks. The rally follows a settlement converting major debt to equity and anticipation of Nov. 18 earnings. The company rebranded in 2023 and focuses on wellness products. Technical signals warn of high volatility and potential pullback after the surge.
3 November 2025
·
Nocera (NCRA) Stock Skyrockets 36% on $300M Digital Asset Deal – Key Facts & Outlook

Nocera (NCRA) Stock Skyrockets 36% on $300M Digital Asset Deal – Key Facts & Outlook

Nocera, Inc. announced a private placement of up to $300 million in senior secured convertible notes to fund a stablecoin-based digital asset treasury and acquisitions. Shares surged as much as 36% pre-market on November 3, 2025, hitting a new 52-week high. The Taiwan-based firm, once focused on aquaculture, has shifted to an acquisition-driven model but remains unprofitable, with revenue down 29% in 2024.
3 November 2025
·
Dominion Energy’s Q3 Shocker: Data Center Boom and Offshore Wind Pay Off in Surging Profits

Dominion Energy’s Q3 Shocker: Data Center Boom and Offshore Wind Pay Off in Surging Profits

Dominion Energy reported Q3 2025 operating earnings of $1.06 per share, beating expectations, and GAAP net income rose to $1.0 billion from $934 million a year ago. Revenue jumped 15% to $4.53 billion, driven by strong power demand in Virginia and South Carolina. The company narrowed full-year guidance and is contracting to supply 47 GW of new data center capacity. Offshore wind project costs rose to $11.2 billion but remains on schedule.
3 November 2025
···
Biohaven Stock’s Wild Ride: Big Drops, Big Hopes as FDA Verdict Nears

Biohaven Stock’s Wild Ride: Big Drops, Big Hopes as FDA Verdict Nears

Biohaven Ltd. shares dropped over 20% in pre-market trading Nov. 3, falling to about $13.40 after closing at $17.20 on Oct. 31. The decline comes ahead of an FDA decision on troriluzole, expected in Q4 2025. The stock is down roughly 66% year-over-year, far underperforming biotech peers. Biohaven reported $408 million in cash mid-2025 but posted a $198 million net loss in Q2.
3 November 2025
·
Iovance Biotherapeutics (IOVA): TIL Cancer Breakthrough or Biotech Bust?

Iovance Biotherapeutics (IOVA): TIL Cancer Breakthrough or Biotech Bust?

Iovance shares traded near $2.00 on Nov. 3, 2025, with a market cap around $700 million after plunging 70% year-to-date. The company’s Amtagvi, the first FDA-approved TIL therapy for advanced melanoma, also secured Health Canada approval. Interim Phase 2 data showed a 25.6% response rate for lifileucel in advanced NSCLC. Iovance will hold its Q3 earnings call on Nov. 6.
3 November 2025
Phio Pharmaceuticals (PHIO) Stock Skyrockets on Breakthrough Skin Cancer Trial Results – In-Depth Analysis & 2025 Outlook

Phio Pharmaceuticals (PHIO) Stock Skyrockets on Breakthrough Skin Cancer Trial Results – In-Depth Analysis & 2025 Outlook

Phio Pharmaceuticals’ shares surged over 100% on November 3 after announcing positive Phase 1b results for its PH-762 skin cancer therapy, with one patient achieving full tumor clearance. No serious adverse effects were reported at any dose. The company, with a $12 million pre-rally market cap and no revenue, holds enough cash to fund operations into 2026 but will need more capital for larger trials. Analyst outlooks remain mixed.
3 November 2025
··
1 … 1,586 1,587 1,588 1,589 1,590 … 1,848

Stock Market Today

  • Morgan Stanley Unveils Cheapest Spot Bitcoin ETF MSBT with Strong Launch
    April 11, 2026, 10:25 PM EDT. Morgan Stanley has launched the MSBT, the lowest-cost spot Bitcoin ETF in the U.S., charging an annual fee of just 0.14%, undercutting rivals like BlackRock's IBIT at 0.25%. MSBT drew about $34 million in inflows on its opening day with 1.6 million shares traded, marking a standout ETF debut, according to Bloomberg analyst Eric Balchunas. The new ETF gives Morgan Stanley's 16,000 financial advisors a direct way to offer Bitcoin exposure to clients, keeping fees within the bank rather than sending assets to competitors. This move positions Morgan Stanley uniquely in the growing Bitcoin ETF space, which has seen positive inflows recently after months of outflows. The fee advantage especially benefits high-net-worth clients investing six or seven figures.

Latest article

India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

11 April 2026
Lockheed Martin said it is not in direct talks with India over the F-35, clarifying that any approach must go through official U.S. and Indian channels under the Foreign Military Sales process. Indian officials confirmed no formal discussions on acquiring the F-35 have begun. India recently approved a $40 billion military upgrade, including other fighter jets, while Lockheed’s F-21 remains in a separate competition.
Why SNOW Stock Is Falling Again: Snowflake Nears 52-Week Low as AI Worries Hit Software

Why SNOW Stock Is Falling Again: Snowflake Nears 52-Week Low as AI Worries Hit Software

11 April 2026
Snowflake shares fell 8.4% to $121.11 on Friday after an 11.7% drop Thursday, as investors sold off software stocks amid concerns over new AI tools from Anthropic and OpenAI. The stock now trades just above its 52-week low. The S&P 500 Software and Services Index is down 25.5% for the year. Snowflake reported fourth-quarter product revenue of $1.23 billion, up 30% from a year earlier.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 11.04.2026

11 April 2026
LIVEMarkets rolling coverageStarted: April 11, 2026, 12:00 AM EDTUpdated: April 11, 2026, 10:51 PM EDT Morgan Stanley Unveils Cheapest Spot Bitcoin ETF MSBT with Strong Launch April 11, 2026, 10:25 PM EDT. Morgan Stanley has launched the MSBT, the **lowest-cost spot Bitcoin ETF** in the U.S., charging an annual fee of just 0.14%, undercutting rivals like BlackRock's IBIT at 0.25%. MSBT drew about $34 million in inflows on its opening day with 1.6 million shares traded, marking a standout ETF debut, according to Bloomberg analyst Eric Balchunas. The new ETF gives Morgan Stanley's 16,000 financial advisors a direct way to
Go toTop